ID

14352

Descripción

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00670150

Link

https://clinicaltrials.gov/show/NCT00670150

Palabras clave

  1. 12/4/16 12/4/16 -
Subido en

12 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Promyelocytic Leukemia NCT00670150

Eligibility Acute Promyelocytic Leukemia NCT00670150

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis patients must have a clinical diagnosis of acute promyelocytic leukemia (apl) morphology or fab m3 variant confirmed by rt-pcr assay for pml-rarα or chromosome analysis/fish showing t(15:17) translocation. a patient may be entered prior to confirmatory studies, but a patient who is subsequently found to be pml-rarα
Descripción

Acute Promyelocytic Leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023487
prior treatment the patient must not have received any systemic definitive treatment for apl, including cytotoxic chemotherapy, retinoids or arsenic trioxide. prior therapy with corticosteroids, hydroxyurea or leukapheresis will not exclude the patient.
Descripción

Definitive Treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2986592
Patients must be of age eighteen (18) or above.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Bilirubin equal or less than 1.5 times the upper limit of normal.
Descripción

Bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005437
Creatinine equal or less than 1.5 times the upper limit of normal
Descripción

Creatinine, Serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
Pregnancy / nursing status
Descripción

Pregnancy and Lactation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2986850
Patients entered into this study should be non-pregnant and non-nursing and should not plan on becoming pregnant while on treatment. treatment under this protocol would expose an unborn child to significant risks. treatment. women and men of reproductive potential should agree to use an effective means of birth control. there is an extremely high risk of fetal malformation if pregnancy occurs while on treatment in any amount with retinoid drugs even for short periods.
Descripción

Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
non-apl, aml patients should be excluded from the study.
Descripción

Acute Myelocytic Leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023467
Other serious illnesses which would limit survival to 1 year.
Descripción

Life expectancy shortened

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1504437
psychiatric conditions which would prevent compliance with treatment or informed consent.
Descripción

Mental disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004936
uncontrolled or severe cardiovascular disease. this would include history of a recent acute myocardial infarction, uncontrolled congestive heart failure, or active angina.
Descripción

Cardiovascular Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
aids or hiv positive patients, although hiv test is not required for accrual.
Descripción

HIV

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682

Similar models

Eligibility Acute Promyelocytic Leukemia NCT00670150

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Acute Promyelocytic Leukemia
Item
diagnosis patients must have a clinical diagnosis of acute promyelocytic leukemia (apl) morphology or fab m3 variant confirmed by rt-pcr assay for pml-rarα or chromosome analysis/fish showing t(15:17) translocation. a patient may be entered prior to confirmatory studies, but a patient who is subsequently found to be pml-rarα
boolean
C0023487 (UMLS CUI [1])
Definitive Treatment
Item
prior treatment the patient must not have received any systemic definitive treatment for apl, including cytotoxic chemotherapy, retinoids or arsenic trioxide. prior therapy with corticosteroids, hydroxyurea or leukapheresis will not exclude the patient.
boolean
C2986592 (UMLS CUI [1])
Age
Item
Patients must be of age eighteen (18) or above.
boolean
C0001779 (UMLS CUI [1])
Bilirubin
Item
Bilirubin equal or less than 1.5 times the upper limit of normal.
boolean
C0005437 (UMLS CUI [1])
Creatinine, Serum
Item
Creatinine equal or less than 1.5 times the upper limit of normal
boolean
C0201976 (UMLS CUI [1])
Pregnancy and Lactation Status
Item
Pregnancy / nursing status
boolean
C2986850 (UMLS CUI [1])
Contraceptive methods
Item
Patients entered into this study should be non-pregnant and non-nursing and should not plan on becoming pregnant while on treatment. treatment under this protocol would expose an unborn child to significant risks. treatment. women and men of reproductive potential should agree to use an effective means of birth control. there is an extremely high risk of fetal malformation if pregnancy occurs while on treatment in any amount with retinoid drugs even for short periods.
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acute Myelocytic Leukemia
Item
non-apl, aml patients should be excluded from the study.
boolean
C0023467 (UMLS CUI [1])
Life expectancy shortened
Item
Other serious illnesses which would limit survival to 1 year.
boolean
C1504437 (UMLS CUI [1])
Mental disorders
Item
psychiatric conditions which would prevent compliance with treatment or informed consent.
boolean
C0004936 (UMLS CUI [1])
Cardiovascular Diseases
Item
uncontrolled or severe cardiovascular disease. this would include history of a recent acute myocardial infarction, uncontrolled congestive heart failure, or active angina.
boolean
C0007222 (UMLS CUI [1])
HIV
Item
aids or hiv positive patients, although hiv test is not required for accrual.
boolean
C0019682 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial